Circulation：观点文章：应对心血管病“达摩克里斯之剑”，葛均波院士开出五个处方

2018-07-29 文韬中国循环杂志

xujie.L

医生/

7月24日，Circulation杂志葛均波院士观点文章。文章称，心血管病“达摩克利斯之剑”正悬在中国人民头上。

达摩克利斯之剑，中文或称"悬顶之剑"。源自古希腊传说：迪奥尼修斯国王请他的朋友达摩克利斯赴宴，让他坐在用一根马鬃悬挂的一把寒光闪闪的利剑下，意指令人处于一种危机状态。

7月24日，Circulation杂志葛均波院士观点文章。文章称，心血管病“达摩克利斯之剑”正悬在中国人民头上。

文章指出，中国冠心病之前很少见。上世纪50年代，上海大型中心医院每年收治的心梗患者不到10人。现在则明显增加。

如何应对心血管病“达摩克利斯之剑”？他开出的药方如下：

1、开展促进健康生活方式的教育活动，包括纠正吸烟、超重、高血压、高血脂、高血糖及缺乏体力活动等危险因素。

2、建立起切实可行的疾病管理模式，管理无症状的高血压、糖尿病和高脂血症患者。每年规律进行健康体检，检测血压、血脂和血糖，可以识别高危人群并给予适宜的治疗。

3、建立标准化的分级诊疗网络。完善社区和省级医院双向转诊。另外，加快卒中单元、心衰单元、胸痛中心，以及康复教育以及心血管多级康复/二级预防模式的建设。

4、改善环境污染，经济的长远发展不能以牺牲环境为代价。

5、大力开展研究。我国心血管病在很多方面与其他国家存在差异，因此需要大力开展研究来找出疾病的潜在发病机制，才能制定最佳的诊疗方案。

作者也指出，防治心血管病需要全社会齐心协力，只有政府部门、学科带头人、社区医务工作者、患者及家庭成员共同努力，才能延缓心血管病的流行速度。

原始出处：Chengxing Shen, Junbo Ge. Epidemic of Cardiovascular Disease in China: Current Perspective and Prospectsfor the Future. Circulation, 2018, 138: 342–344.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-09-28 Luyuxie_17

#血管病#

56 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-31 hjwang86

#葛均波院士#

71 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-30 张新亮1853311252142e2fm

好文章学习了

95 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-30 liumin1987

好，学习了。

94 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-30 smartxiuxiu

可以

84 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-29 junJUN

院士是学术至高点，也是大家必争之地呀

88 0
[GetPortalCommentsPageByObjectIdResponse(id=1644693, encodeId=d2de1644693ab, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 28 06:29:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626268, encodeId=f9c2162626886, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Tue Jul 31 01:29:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335046, encodeId=b7353350462e, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Mon Jul 30 07:07:07 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335042, encodeId=9b4f335042fd, content=好，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Jul 30 07:01:23 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334997, encodeId=9b8a33499e39, content=可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Jul 30 00:10:26 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048999, encodeId=a5b0104899902, content=院士是学术至高点，也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Jul 29 13:29:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334888, encodeId=32943348884c, content=预防是关键。, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sun Jul 29 10:55:47 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
2018-07-29 医者仁心5538

预防是关键。

91 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管

Circulation：观点文章：应对心血管病“达摩克里斯之剑”，葛均波院士开出五个处方

相关资讯

科室

工具

服务